PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Cansino Biologics Inc. (6185.HK)

Equity · Currency in HKD · Last updated Dec 7, 2023
SummaryFinancials

Company Info

ISINCNE100003F01
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market CapHK$13.03B
EPS-HK$5.77
PE Ratio134.23
Revenue (TTM)HK$502.83M
Gross Profit (TTM)-HK$183.71M
EBITDA (TTM)-HK$1.62B
Year RangeHK$20.50 - HK$95.70
Target PriceHK$83.49

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of HK$10,000 in Cansino Biologics Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
-15.42%
4.77%
6185.HK (Cansino Biologics Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 6185.HK

Cansino Biologics Inc.

Return

Cansino Biologics Inc. had a return of -64.64% year-to-date (YTD) and -71.50% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-64.64%18.49%
1 month-14.80%4.20%
6 months-17.77%6.60%
1 year-71.50%15.43%
5 years (annualized)N/A11.59%
10 years (annualized)N/A9.70%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-21.56%-10.14%12.24%-21.64%6.09%1.43%10.30%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Cansino Biologics Inc. (6185.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
6185.HK
Cansino Biologics Inc.
-1.27
^GSPC
S&P 500
1.00

Sharpe Ratio

The current Cansino Biologics Inc. Sharpe ratio is -1.27. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JulyAugustSeptemberOctoberNovemberDecember
-1.27
0.72
6185.HK (Cansino Biologics Inc.)
Benchmark (^GSPC)

Dividend History

Cansino Biologics Inc. granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.00 per share.


PeriodTTM2022
DividendHK$0.00HK$0.94

Dividend yield

0.00%1.40%

Monthly Dividends

The table displays the monthly dividend distributions for Cansino Biologics Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.94HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-94.49%
-6.05%
6185.HK (Cansino Biologics Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Cansino Biologics Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Cansino Biologics Inc. was 95.12%, occurring on Oct 4, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.12%Feb 18, 2021646Oct 4, 2023
-47.24%Aug 3, 202062Nov 2, 202058Jan 25, 2021120
-33.66%May 21, 20206May 28, 202030Jul 13, 202036
-31.39%Apr 17, 201933Jun 6, 2019117Nov 22, 2019150
-21.17%Mar 5, 20203Mar 9, 202010Mar 23, 202013

Volatility Chart

The current Cansino Biologics Inc. volatility is 13.26%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
13.26%
2.96%
6185.HK (Cansino Biologics Inc.)
Benchmark (^GSPC)